Gunning, M G <br/><br/>
Acipimox does not augment thallium-201 redistribution in the fasting state.  [electronic resource] 

 -  Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology   
 - 620-5 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1071-3581 
<br/><br/><label>Standard No.: </label>10.1016/s1071-3581(99)90099-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenosine<br/>Administration, Oral<br/>Adult<br/>Aged<br/>Coronary Disease--diagnostic imaging<br/>Cross-Over Studies<br/>Double-Blind Method<br/>Exercise Test<br/>Fasting--metabolism<br/>Female<br/>Glucose--administration & dosage<br/>Heart--diagnostic imaging<br/>Humans<br/>Hypolipidemic Agents--administration & dosage<br/>Insulin--administration & dosage<br/>Male<br/>Middle Aged<br/>Myocardial Ischemia--diagnostic imaging<br/>Myocardium--metabolism<br/>Prospective Studies<br/>Pyrazines--administration & dosage<br/>Radiopharmaceuticals--pharmacokinetics<br/>Thallium Radioisotopes--pharmacokinetics<br/>Tomography, Emission-Computed, Single-Photon<br/>Vasodilator Agents